# Study to Evaluate the Effects of TRV120027 in Patients With Heart Failure

> **NCT01187836** · PHASE1,PHASE2 · COMPLETED · sponsor: **Trevena Inc.** · enrollment: 33 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** TRV120027
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01187836
- **Lead sponsor:** Trevena Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2017-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01187836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01187836, "Study to Evaluate the Effects of TRV120027 in Patients With Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01187836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*